AMN Healthcare Services Inc.

12/02/2024 | Press release | Distributed by Public on 12/02/2024 14:03

Statement of Changes in Beneficial Ownership - Form 4

Ownership Submission
FORM 4
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287 Estimated average burden hours per response... 0.5
(Print or Type Responses)
1. Name and Address of Reporting Person *
Grace Caroline
2. Issuer Name and Ticker or Trading Symbol
AMN HEALTHCARE SERVICES INC [AMN] 		5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
__X__ Director _____ 10% Owner
__X__ Officer (give title below) _____ Other (specify below)
Chief Executive Officer
(Last) (First) (Middle)
2999 OLYMPUS BOULEVARD, SUITE 500 		3. Date of Earliest Transaction (Month/Day/Year)
11/28/2024
(Street)
DALLAS, TX 75019 		4. If Amendment, Date Original Filed (Month/Day/Year)
 6. Individual or Joint/Group Filing (Check Applicable Line)
_X_ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person
(City) (State) (Zip)
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security
(Instr. 3) 		2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code
(Instr. 8) 		4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5) 		5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4) 		6. Ownership Form: Direct (D) or Indirect (I)
(Instr. 4) 		7. Nature of Indirect Beneficial Ownership
(Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 11/28/2024 M(1) 5,389 A $ 0 33,201(2) D
Common Stock 11/28/2024 F(3) 2,121 D $26.29 31,080 D
Common Stock 11/28/2024 M(4) 2,694 A $ 0 33,774 D
Common Stock 11/28/2024 F(3) 1,022 D $26.29 32,752 D
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number. SEC 1474 (9-02)
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security
(Instr. 3) 		2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code
(Instr. 8) 		5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4, and 5) 		6. Date Exercisable and Expiration Date
(Month/Day/Year) 		7. Title and Amount of Underlying Securities
(Instr. 3 and 4) 		8. Price of Derivative Security
(Instr. 5) 		9. Number of Derivative Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 4) 		10. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
(Instr. 4) 		11. Nature of Indirect Beneficial Ownership
(Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Restricted Stock Units (5) 11/28/2024 M 5,389 (6) (7) Common Stock 5,389 $ 0 5,552 D
Restricted Stock Units (5) 11/28/2024 M 2,694 (6) (7) Common Stock 2,694 $ 0 2,776 D

Reporting Owners

Reporting Owner Name / Address Relationships
Director 10% Owner Officer Other
Grace Caroline
2999 OLYMPUS BOULEVARD
SUITE 500
DALLAS, TX 75019 		X Chief Executive Officer

Signatures

/s/ Caroline Grace 11/29/2024
**Signature of Reporting Person Date

Explanation of Responses:

* If the form is filed by more than one reporting person, see Instruction 4(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
(1) Common stock acquired on the vesting of Restricted Stock Units.
(2) Includes 470 shares of AMN Common Stock purchased pursuant to the AMN Healthcare Employee Stock Purchase Plan ("ESPP") on March 28, 2024 and 164 shares of AMN Common Stock purchased pursuant to the ESPP on September 30, 2024.
(3) Number of shares withheld for tax purposes.
(4) Common stock acquired on the vesting of restricted stock units.
(5) The Restricted Stock Units reflected in this row were granted pursuant to the AMN Healthcare 2017 Equity Plan. Each Restricted Stock Unit represents a contingent right to receive one share of AMN Common Stock.
(6) The Restricted Stock Units reflected in this row were granted on November 28, 2022 and vest on the first, second and third anniversary of the grant date and the grantee's provision of three periods of credited service.
(7) Restricted Stock Units do not have an expiration date.
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure. Potential persons who are to respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB number.